Abstract Details

Title Effectiveness and Safety of a New Zolmitriptan Rapid Absorption Microneedle Array (M207) for the Acute Treatment of Migraine (The ZOTRIP Study)

Topic Headache

Presentation(s) P4 - (-)

Poster/Presentation
Number 125

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Egilius L. Spierings, MD, PhD (MEDVADIS RESEARCH) PRESENTER	Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Manistee. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Donald Kellerman (Zosano)	No disclosure on file
Pete Schmidt	No disclosure on file

��ɫ��